About GeneCapture
GeneCapture is a private company based in Huntsville, Alabama. It has reported $2,491,103 raised in 11 offerings on Form D since September 2012. Its chief executive is Peggy Sammon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 26, 2026 | $50,000of $3.0M target | 2 | $25,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 27, 2024 | Dec 6, 2024 | $500,000of $1.5M target | 1 | $500K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 1, 2021 | Sep 2, 2021 | $1,200,000of $6.0M target | 1 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Sep 15, 2020 | Sep 15, 2020 | $124,997of $381K target | 2 | $62,499 | EquityRule 506(c) | Form D ↗ |
| Jun 19, 2019 | Jun 21, 2019 | $38,365of $1.0M target | 3 | $12,788 | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2018 | Jun 27, 2018 | $150,000fully sold | 2 | $75,000 | EquityRule 506(b) | Form D ↗ |
| Oct 19, 2017 | Oct 23, 2017 | $55,000of $169K target | 3 | $18,333 | EquityRule 506(b) | Form D ↗ |
| May 2, 2017 | May 2, 2017 | $110,741of $280K target | 4 | $27,685 | EquityRule 506(b) | Form D ↗ |
| Mar 8, 2016 | Mar 8, 2016 | $120,000of $500K target | 2 | $60,000 | EquityRule 506(b) | Form D ↗ |
| May 30, 2014 | May 30, 2014 | $142,000of $430K target | 4 | $35,500 | EquityRule 506(b) | Form D ↗ |
| Not yet | Sep 28, 2012 | $0of $400K target | 0 | — | Equity06 | Form D ↗ |
| Total, 11 offerings | $2,491,103 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GeneCapture's Form D filed Feb 26, 2026.